diltiazem has been researched along with Disease Exacerbation in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, D; Aparasu, RR; Deshmukh, AA; Goyal, P; Holmes, HM; Kobayashi, M; Kwak, MJ | 1 |
| Beanlands, RS; Burns, KD; Croteau, E; DaSilva, JN; deKemp, RA; Hadizad, T; Ismail, B | 1 |
| Anderson, ME; Benitez, GE; Lehman, SJ; Lynn, ML; Strom, J; Tal-Grinspan, L; Tardiff, JC | 1 |
| Kayikçioğlu, M; Kültürsay, H | 1 |
| Takatsu, F; Watarai, M | 1 |
| Nicholson, DJ; Passen, EL; Wann, S | 1 |
| Furrer, F; Giambarba, C | 1 |
| Pasantes-Morales, H; Quesada, O; Quiroz, H | 1 |
| Hirata, Y; Hiroi, Y; Maemura, K; Nagai, R; Nakamura, F; Nakao, T; Ohno, M; Takeda, N; Tsuchiya, N | 1 |
| Hidelaratchi, MD; Pathirana, KD | 1 |
| Akdogan, O; Dere, H; Giray, SG; Ozcan, I; Ozogul, C; Selcuk, A | 1 |
| Chrysant, SG; Conradi, E; Gavras, H; Goldstein, R; Marbury, TC; Niederman, AL | 1 |
| Schwartzkopff, B; Strauer, BE | 1 |
1 review(s) available for diltiazem and Disease Exacerbation
| Article | Year |
|---|---|
[Current approach to the treatment of pulmonary arterial hypertension and our experience in the Cardiology Department of Medicine Faculty of Ege University].
Topics: Antihypertensive Agents; Diltiazem; Disease Progression; Epoprostenol; Humans; Hypertension, Pulmonary; Iloprost; Nifedipine; Turkey; Vasodilator Agents | 2009 |
2 trial(s) available for diltiazem and Disease Exacerbation
| Article | Year |
|---|---|
Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study.
Topics: Adolescent; Adult; Angiography; Antioxidants; Calcium Channel Blockers; Child; Diltiazem; Disease Progression; Double-Blind Method; Electroretinography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Photoreceptor Cells, Vertebrate; Retinitis Pigmentosa; Taurine; Visual Acuity; Visual Fields; Vitamin E | 2002 |
Evaluation of enalapril combined with diltiazem ER in patients with stage 3-4 essential hypertension.
Topics: Adult; Antihypertensive Agents; Diltiazem; Disease Progression; Drug Therapy, Combination; Enalapril; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged | 1998 |
10 other study(ies) available for diltiazem and Disease Exacerbation
| Article | Year |
|---|---|
Prescribing Trend of Inappropriate Medications in Outpatient Clinics for Older Adults With Heart Failure in the United States: NAMCS 2012 to 2016.
Topics: Aged; Ambulatory Care; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Calcium Channel Blockers; Citalopram; Cyclooxygenase Inhibitors; Diltiazem; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Heart Failure; Humans; Hypoglycemic Agents; Potentially Inappropriate Medication List; Practice Patterns, Physicians'; Sitagliptin Phosphate; Sotalol; Thiazolidinediones; Tumor Necrosis Factor Inhibitors; United States | 2021 |
Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Diltiazem; Disease Progression; Enalapril; Gene Expression Regulation; Heart; Kidney; Male; Organ Size; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Regional Blood Flow; Renal Insufficiency, Chronic | 2017 |
Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.
Topics: Animals; Atrial Remodeling; Calcium; Calcium Channel Blockers; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomyopathy, Hypertrophic; Diltiazem; Disease Models, Animal; Disease Progression; Echocardiography; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis, Site-Directed; Peptides; Phosphorylation; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Troponin T; Ventricular Function | 2019 |
Mild stenosis makes prognosis of vasospastic angina worse.
Topics: Adult; Aged; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Death, Sudden, Cardiac; Diltiazem; Disease Progression; Electrocardiography; Female; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Sex Factors | 2011 |
Computed tomography angiography for right ventricular function in an adult with complex congenital heart disease.
Topics: Adrenergic beta-1 Receptor Antagonists; Calcium Channel Blockers; Coronary Angiography; Diltiazem; Disease Progression; Humans; Male; Metoprolol; Middle Aged; Tetralogy of Fallot; Tomography, X-Ray Computed; Ventricular Dysfunction, Right; Ventricular Function, Right | 2010 |
[The choked heart].
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Bisoprolol; Calcium Channel Blockers; Cardiac Output, Low; Diagnosis, Differential; Diltiazem; Disease Progression; Dose-Response Relationship, Drug; Drug Interactions; Emergencies; Female; Humans; Shock, Cardiogenic; Verapamil | 2012 |
Exacerbation of Lambert-Eaton myasthenic syndrome caused by an L-type Ca2+ channel antagonist.
Topics: Aged; Atherectomy, Coronary; Calcium Channel Blockers; Coronary Stenosis; Diltiazem; Disease Progression; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Muscle, Skeletal; Myocardial Ischemia | 2003 |
Exacerbation of symptoms due to diltiazem in a patient with Lambert-Eaton myasthenic myopathic syndrome.
Topics: Aged; Diltiazem; Disease Progression; Electromyography; Follow-Up Studies; Humans; Lambert-Eaton Myasthenic Syndrome; Male; Myocardial Ischemia; Neurologic Examination; Risk Assessment; Severity of Illness Index; Sri Lanka | 2004 |
Topical application of calcium channel blockers to reduce the progression of experimentally induced myringosclerosis and tympanosclerosis.
Topics: Administration, Topical; Animals; Calcium Channel Blockers; Diltiazem; Disease Models, Animal; Disease Progression; Ear, Middle; Epithelium; Fibroblasts; Guinea Pigs; Leukocytes, Mononuclear; Male; Mucous Membrane; Neutrophils; Otitis Media; Otosclerosis; Pneumococcal Infections; Temporal Bone; Tympanic Membrane | 2008 |
Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function, and coronary reserve.
Topics: Antihypertensive Agents; Arterioles; Bisoprolol; Blood Pressure; Coronary Circulation; Diastole; Diltiazem; Disease Progression; Enalapril; Fibrosis; Heart Ventricles; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Isradipine; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |